Directional is the fastest growing segment, North America is the largest regional market
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
The escalating burden of cardiovascular diseases directly translates into a greater patient pool requiring intervention, including atherectomy procedures. Atherosclerosis, a primary cause of conditions such as peripheral artery disease and coronary artery disease, necessitates mechanical plaque removal to restore blood flow and prevent severe complications. According to the Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators, in their "Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023" published in *JACC* in September 2025, there were 626 million prevalent cases of cardiovascular disease globally in 2023. This highlights the extensive and current need for effective treatment modalities.Key Market Challenges
The elevated cost of atherectomy devices presents a substantial impediment to the growth of the global market. This financial barrier directly affects the accessibility and widespread adoption of these advanced interventional tools within diverse healthcare systems. High procurement costs can strain hospital budgets, particularly in regions with limited healthcare spending, thereby restricting the acquisition and availability of atherectomy technology. This limitation directly impacts the volume of procedures that can be performed, slowing market penetration and expansion.Key Market Trends
The rising adoption of combination therapies that integrate atherectomy with drug-coated balloons (DCBs) is emerging as a key trend shaping the interventional cardiology and vascular treatment landscape. This combined approach is designed to optimise procedural outcomes by mechanically removing plaque through atherectomy, followed by targeted local drug delivery to reduce the risk of restenosis, thereby offering a more comprehensive treatment solution for complex vascular lesions. Clinicians are increasingly acknowledging the clinical value of this synergistic strategy, particularly in improving long-term vessel patency and minimising the need for repeat interventions.Key Market Players Profiled:
- Braun Melsungen AG
- Abbott Laboratories, Inc.
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Medtronic plc
- Becton, Dickinson, and Company
- Terumo Corporation
- Cardinal Health Inc.
- AngioDynamics Inc.
- Avinger Inc.
Report Scope:
In this report, the Global Atherectomy Devices Market has been segmented into the following categories:By Product:
- Directional
- Rotational
- Laser
- Orbital
By Application:
- Peripheral
- Cardiovascular
- Neurovascular
By End User:
- Hospitals & Surgical Centres
- Ambulatory Care Centres
- Others
By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Atherectomy Devices Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
The companies profiled in this Atherectomy Devices market report include:- Braun Melsungen AG
- Abbott Laboratories, Inc.
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Medtronic plc
- Becton, Dickinson, and Company
- Terumo Corporation
- Cardinal Health Inc.
- AngioDynamics Inc.
- Avinger Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | November 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.12 Billion |
| Forecasted Market Value ( USD | $ 1.69 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


